Somatostatin Receptor Ligand device attribute survey

A survey to identify the key Somatostatin Receptor Ligand (SRL) device attributes that lead to the best injection experience in people living with acromegaly and NET, as well as those caring for them. The surveys have been developed by a Scientific Committee comprising Endocrinologists, Nurses and Patient Advocates from the World Alliance of Pituitary Organizations (WAPO) and the International Neuroendocrine Cancer Alliance (INCA).

The short surveys collect are designed for people living with acromegaly and NET, caregivers, nurses and physicians.

Click on the buttons to complete the surveys.

The surveys have been developed in partnership with INCA and WAPO.